1. Home
  2. GHRS vs YORW Comparison

GHRS vs YORW Comparison

Compare GHRS & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • YORW
  • Stock Information
  • Founded
  • GHRS 2018
  • YORW 1816
  • Country
  • GHRS Ireland
  • YORW United States
  • Employees
  • GHRS N/A
  • YORW N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • YORW Water Supply
  • Sector
  • GHRS Health Care
  • YORW Utilities
  • Exchange
  • GHRS Nasdaq
  • YORW Nasdaq
  • Market Cap
  • GHRS 583.1M
  • YORW 481.3M
  • IPO Year
  • GHRS 2021
  • YORW N/A
  • Fundamental
  • Price
  • GHRS $12.03
  • YORW $32.66
  • Analyst Decision
  • GHRS Strong Buy
  • YORW
  • Analyst Count
  • GHRS 8
  • YORW 0
  • Target Price
  • GHRS $30.63
  • YORW N/A
  • AVG Volume (30 Days)
  • GHRS 149.3K
  • YORW 68.9K
  • Earning Date
  • GHRS 05-08-2025
  • YORW 05-06-2025
  • Dividend Yield
  • GHRS N/A
  • YORW 2.69%
  • EPS Growth
  • GHRS N/A
  • YORW N/A
  • EPS
  • GHRS N/A
  • YORW 1.37
  • Revenue
  • GHRS N/A
  • YORW $75,787,000.00
  • Revenue This Year
  • GHRS N/A
  • YORW $7.50
  • Revenue Next Year
  • GHRS N/A
  • YORW $6.33
  • P/E Ratio
  • GHRS N/A
  • YORW $23.89
  • Revenue Growth
  • GHRS N/A
  • YORW 3.45
  • 52 Week Low
  • GHRS $6.00
  • YORW $29.86
  • 52 Week High
  • GHRS $20.50
  • YORW $41.96
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 58.82
  • YORW 44.33
  • Support Level
  • GHRS $10.66
  • YORW $32.22
  • Resistance Level
  • GHRS $13.00
  • YORW $33.04
  • Average True Range (ATR)
  • GHRS 0.96
  • YORW 0.68
  • MACD
  • GHRS 0.12
  • YORW -0.00
  • Stochastic Oscillator
  • GHRS 67.84
  • YORW 58.00

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

About YORW York Water Company (The)

The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and eleven wastewater collection and treatment systems. The company operates within its franchised territory, which covers more than 57 municipalities within four counties in south-central Pennsylvania.

Share on Social Networks: